Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus, Type 1 or 2”

188 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 188 results

Large-scale testing (Phase 3)Study completedNCT01709929
What this trial is testing

Safety of Insulin Detemir for the Treatment of Insulin Dependent Type 1 or Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 2,287
Large-scale testing (Phase 3)Study completedNCT00254501
What this trial is testing

Empowering Patients to Better Manage Diabetes Through Self-Care

Who this might be right for
Type I or Type II Diabetes (Excludes Gestational Diabetes)
Oregon State University 69
Testing effectiveness (Phase 2)Active Not RecruitingNCT05608044
What this trial is testing

Botensilimab and Balstilimab for the Treatment of Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Agenus Inc. 234
Testing effectiveness (Phase 2)WithdrawnNCT04661917
What this trial is testing

A Trial to Learn More About How BAY2327949 Works and How Safe it is in Patients Whose Kidneys Are Damaged Due to High Blood Sugar Levels or High Blood Pressures, and With a Further Disease of the Heart or the Blood Vessels.

Who this might be right for
Chronic Kidney DiseaseDiabetic Kidney Disease
Bayer
Not applicableUnknownNCT02023489
What this trial is testing

Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations

Who this might be right for
Type 2 Diabetes MellitusPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric Hypercalcemia+2 more
Medical University of Vienna 90
Large-scale testing (Phase 3)Study completedNCT00773279
What this trial is testing

Efficacy, Safety and Preference Study of a Insulin Pen PDS290 vs. a Novo Nordisk Marketed Insulin Pen in Diabetics

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2+1 more
Novo Nordisk A/S 242
Large-scale testing (Phase 3)Study completedNCT00231387
What this trial is testing

Rosiglitazone And Plaque Study for Type 2 Diabetes Mellitus

Who this might be right for
Non-insulin-dependent Diabetes Mellitus
GlaxoSmithKline 60
Testing effectiveness (Phase 2)Study completedNCT00320021
What this trial is testing

Effect of Pyridorin in Patients With Diabetic Nephropathy

Who this might be right for
Diabetic Nephropathy
BioStratum 80
Not applicableStudy completedNCT00834938
What this trial is testing

Comparison Between Patients With or Without Diabetes Recovery After Bariatric Surgery

Who this might be right for
DiabetesBariatric SurgeryObesity
University of Campinas, Brazil 24
Large-scale testing (Phase 3)Study completedNCT01754259
What this trial is testing

Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CAD

Who this might be right for
Diabetes, Type IDiabetes, Type IIAngina+1 more
Brigham and Women's Hospital 47
Testing effectiveness (Phase 2)Looking for participantsNCT05267626
What this trial is testing

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

Who this might be right for
Advanced Solid TumorMetastatic CancerCutaneous Melanoma+1 more
Aulos Bioscience, Inc. 159
Large-scale testing (Phase 3)Study completedNCT02207374
What this trial is testing

A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly in Monotherapy or in Combination With One OAD in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 601
Testing effectiveness (Phase 2)UnknownNCT05333835
What this trial is testing

A Trial Comparing the Efficacy and Safety of HR17031 Injection to INS068 Injection and to SHR20004 Injection in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 455
Large-scale testing (Phase 3)Study completedNCT01009580
What this trial is testing

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 447
Not applicableStudy completedNCT06288269
What this trial is testing

Factors of Control Hypertension or Type 2 Diabetes on the Severity of Stroke and Survival Rates Within 1 Year in Trat

Who this might be right for
StrokeHypertensionType2diabetes
Phrapokklao Hospital,Thailand 291
Large-scale testing (Phase 3)Study completedNCT01766362
What this trial is testing

Incidence of Macular Edema After Panretinal Photocoagulation (PRPC) Performed in a Single Session Versus Four Sessions in Diabetic Patients.

Who this might be right for
Diabetes Type 1 or 2 With Diabetic Retinopathy
Centre Hospitalier Universitaire Dijon 83
Early research (Phase 1)Study completedNCT06615700
What this trial is testing

Phase 1 to Study Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NA-931 in Obese Participants and Patients With Type 2 Diabetes Mellitus

Who this might be right for
Overweight or ObesityType 2 Diabetes
Biomed Industries, Inc. 74
Large-scale testing (Phase 3)Study completedNCT01513590
What this trial is testing

A Trial Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Insulin naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 394
Large-scale testing (Phase 3)Study completedNCT00467376
What this trial is testing

Insulin Glulisine, Insulin Lispro and Insulin Glargine in Type 1 or 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus
Sanofi 485
Not applicableStudy completedNCT00655044
What this trial is testing

Evaluation of Levemir® for the Treatment of Type 1 and 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2
Novo Nordisk A/S 3,637
Next Page